Dupixent (Dupilumab)

Dupixent is a monoclonal antibody used to treat chronic inflammatory conditions such as eczema (atopic dermatitis), asthma, and chronic rhinosinusitis with nasal polyps. By targeting specific pathways in the immune system, Dupixent effectively reduces inflammation and improves quality of life for patients with these chronic conditions. Its broad applicability and significant efficacy have made it a leading therapy in dermatology and respiratory medicine.